US Patent 7824704 Controlled release bioactive agent delivery device

Patent 7824704 was granted and assigned to Surmodics on November, 2010 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Current Assignee

Surmodics

Date Filed

August 15, 2005

Date of Patent

November 2, 2010

Patent Application Number

11203981

Patent Citations Received

‌

US Patent 12005085 Probiotic method and composition for maintaining a healthy vaginal microbiome

‌

US Patent 11833177 Probiotic to enhance an individual's skin microbiome

‌

US Patent 11839632 Topical application of CRISPR-modified bacteria to treat acne vulgaris

‌

US Patent 11951139 Method and system for reducing the likelihood of osteoporosis

‌

US Patent 11951140 Modulation of an individual's gut microbiome to address osteoporosis and bone disease

‌

US Patent 11969445 Probiotic composition and method for controlling excess weight, obesity, NAFLD and NASH

‌

US Patent 11980643 Method and system to modify an individual's gut-brain axis to provide neurocognitive protection

‌

US Patent 11998479 Method and system for addressing adverse effects on the oral microbiome and restoring gingival health caused by sodium lauryl sulphate exposure

‌

US Patent 11998574 Method and system for modulating an individual's skin microbiome

Patent Inventor Names

Signe E. Varner

Eugene de Juan

Laurie R. Lawin

Ralph A. Chappa

Aron B. Anderson

Byron C. Shen

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

7824704

Patent Primary Examiner

‌

Robert A Wax

Find more entities like US Patent 7824704 Controlled release bioactive agent delivery device

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API

By using this site, you agree to our Terms of Service.